The Meals and Drug Administration permitted Wegovy, a higher-dose model of Novo Nordisk’s diabetes drug semaglutide, for long-term weight administration.
In company-funded research, individuals taking Wegovy had common weight lack of 15%, about 34 kilos (15.3 kilograms). Members misplaced weight steadily for 16 months earlier than plateauing. In a comparability group getting dummy photographs, the typical weight reduction was about 2.5%, or simply underneath 6 kilos.
“With present medication, you are going to get possibly 5% to 10% weight discount, typically not even that,” mentioned Dr. Harold Bays, medical director of the Louisville Metabolic and Atherosclerosis Analysis Heart. Bays, who can also be the Weight problems Medication Affiliation’s chief science officer, helped run research of the drug.
Within the U.S., greater than 100 million adults – about 1 in 3 – are overweight.
Dropping even 5% of 1’s weight can convey well being advantages, corresponding to improved power, blood strain, blood sugar and levels of cholesterol, however that quantity typically does not fulfill sufferers who’re targeted on weight reduction, Bays mentioned.
Bays mentioned Wegovy seems far safer than earlier weight problems medication that “have gone down in flames” over security issues. Wegovy’s most typical uncomfortable side effects have been gastrointestinal issues, together with nausea, diarrhea and vomiting. These normally subsided, however led about 5% of research individuals to cease taking it.
The drug carries a possible danger for a sort of thyroid tumor, so it should not be taken by folks with a private or household historical past of sure thyroid and endocrine tumors. Wegovy additionally has a danger of despair and pancreas irritation.
Wegovy (pronounced wee-GOH’-vee) is a synthesized model of a intestine hormone that curbs urge for food. Sufferers inject it weekly underneath their pores and skin. Like different weight-loss medication, it is for use together with train, a nutritious diet and different steps like maintaining a meals diary.
The Danish firm hasn’t disclosed Wegovy’s worth however mentioned will probably be much like the value of Saxenda, an 11-year-old weight reduction drug injected every day that now sometimes prices greater than $1,300 per 30 days with out insurance coverage.
Dr. Archana Sudhu, head of the diabetes program at Houston Methodist Hospital, mentioned Wegovy’s usefulness “all is dependent upon what the value will probably be.” She famous sufferers’ medical insurance plans someday do not cowl weight-loss therapies, placing costly medication out of attain.
Sudhu, who has no connection to Novo Nordisk, plans to modify sufferers who’re overweight and have Sort 2 diabetes to Wegovy. It makes sufferers really feel full sooner and will increase launch of insulin from the pancreas to manage blood sugar, she mentioned. Sufferers would then be extra prone to get motivated to train and eat more healthy, she added.
Wegovy builds on a development wherein makers of comparatively new diabetes medication check them to deal with different situations widespread in diabetics. For instance, fashionable diabetes medication Jardiance and Novo Nordisk’s Victoza now have approvals for decreasing danger of coronary heart assault, stroke and demise in coronary heart sufferers.
Phylander Pannell, 49, of Largo, Maryland, joined a affected person research after cycles of shedding after which regaining weight. She mentioned she obtained Wegovy, labored out a number of instances per week and misplaced 65 kilos over 16 months.
“It helped curb my urge for food and it helped me really feel full quicker,” mentioned Pannell. “It received me on the suitable path.”
Shortly after she completed the research and stopped receiving Wegovy, she regained about half the load. She’s since misplaced a lot of that, began train lessons and acquired dwelling train tools. She’s contemplating going again on Wegovy after it is permitted.
Novo Nordisk is also growing a capsule model.
Observe Linda A. Johnson at https://twitter.com/LindaJ_onPharma.
The Related Press Well being and Science Division receives help from the Howard Hughes Medical Institute’s Division of Science Schooling. The AP is solely answerable for all content material.
Copyright © 2021 by The Related Press. All Rights Reserved.